Skip to main content
. 2023 Oct 19;23:368. doi: 10.1186/s12906-023-04206-2

Table 2.

Baseline demographic characteristics of subjects

Variable NAOs group (n = 42) Placebo group (n = 42) Total (n = 84) p-value1)
Sex (M/F) 0/42 0/42 0/84
Age (years) 36.405 ± 10.258 37.405 ± 9.515 36.905 ± 9.847 0.645
Height (cm) 160.000 ± 5.622 162.071 ± 6.264 161.036 ± 6.007 0.115
Weight (kg) 67.436 ± 6.917 68.690 ± 7.578 68.063 ± 7.239 0.430
BMI (kg/m2) 26.324 ± 2.139 25.963 ± 1.874 26.146 ± 2.009 0.417
PBF (%) 36.933 ± 3.809 36.533 ± 3.243 36.733 ± 3.522 0.606
SBP (mmHg) 122.810 ± 10.530 119.786 ± 9.473 121.298 ± 10.071 0.170
DBP (mmHg) 75.476 ± 9.505 73.214 ± 9.188 74.345 ± 9.361 0.271
Pulse (beats/minute) 78.833 ± 10.329 76.452 ± 8.746 77.643 ± 9.587 0.258
TSH (µIU/mL) 2.148 ± 0.806 2.362 ± 1.050 2.255 ± 0.936 0.297
Alcohol (n, %) 22 (52.38) 17 (40.48) 39 (46.43) 0.2742)
Alcohol (units/week) 5.173 ± 5.328 3.371 ± 2.310 4.387 ± 4.331 0.165
Smoking (n, %) 0 (0.00) 0 (0.00) 0 (0.00)

NAOs, Neoagaro-oligosaccharides; BMI, body mass index; PBF, percent body fat; SBP, systolic blood pressure; DBP, diastolic blood pressure; TSH, thyroid-stimulating hormone

Values are presented as mean ± SD or number (%)

1) Analyzed by independent t-test between the groups

2) Analyzed by chi-square test between the groups